{"url_path":"/sec/mygn/8-k/2026-06-04/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-04","source_url":"https://www.sec.gov/Archives/edgar/data/899923/0000899923-26-000059-index.html","accession_number":"0000899923-26-000059","cik":"0000899923","ticker":"MYGN","issuer_name":"MYRIAD GENETICS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/899923/0000899923-26-000059-index.html","primary_entity_key":"0000899923","primary_entity_name":"MYRIAD GENETICS INC"},"word_count":95,"has_tables":true,"body_markdown":"ITEM 9.01    Financial Statements and Exhibits.\n\nExhibit\nNumber Description\n\n10.1+\n\n[Amended and Restated 2012 Employee Stock Purchase Plan](ex1012012esppasamendedjune.htm), as amended.\n\n10.2+\n[2026 Employee, D](ex102myriad-2026employeedi.htm)[irector and Consultant Equity Incentive Plan](ex102myriad-2026employeedi.htm).\n\n104 Cover Page Interactive Data File (embedded within the Inline XBRL document).\n\n \n\n(+) Management contract or compensatory plan arrangement\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\nMYRIAD GENETICS, INC.\n\nDate: June 4, 2026By:/s/ Benjamin R. Wheeler\n\nBenjamin R. Wheeler\n\nChief Financial Officer"}